‘Smart tampons’ to detect endometriosis lands startup $9 million NextGen Jane, based in Oakland, California, is hoping to use blood wrung from tampons to find early markers of endometriosis and, later, if all goes well, cervical cancer and other disorders. The company disclosed Tuesday that it has secured $9 million in Series A funding led by Material Impact. (TechCrunch)